Literature DB >> 9777688

The application of sample selection models to outcomes research: the case of evaluating the effects of antidepressant therapy on resource utilization.

W H Crown1, R L Obenchain, L Englehart, T Lair, D P Buesching, T Croghan.   

Abstract

Non-randomized studies of treatment effects have come under criticism because of their failure to control for potential biases introduced by unobserved variables correlated with treatment selection and outcomes. This paper describes the basic concepts of sample selection models--a technique used widely in the economics evaluation literature for nearly two decades--and discusses the potential role of these models in outcomes research. In addition, it presents a case study of the application of the sample selection modelling approach to evaluation of the effects of antidepressant therapies on medical expenditures for physician services. This case study presents empirical comparisons of alternative model specifications and discusses practical issues in evaluation of sample selection models. We demonstrate that, in this particular case, sample selection models yield very different conclusions regarding treatment effects than traditional ordinary least squares regression.

Mesh:

Substances:

Year:  1998        PMID: 9777688     DOI: 10.1002/(sici)1097-0258(19980915)17:17<1943::aid-sim885>3.0.co;2-0

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  16 in total

1.  Pharmacoeconomics and health policy. Current applications and prospects for the future.

Authors:  P E Greenberg; A Arcelus; H G Birnbaum; P Y Cremieux; J LeLorier; P Ouellette; M B Slavin
Journal:  Pharmacoeconomics       Date:  1999-11       Impact factor: 4.981

2.  Initial treatment choice in depression: impact on medical expenditures.

Authors:  E T Edgell; T R Hylan; J R Draugalis; S J Coons
Journal:  Pharmacoeconomics       Date:  2000-04       Impact factor: 4.981

3.  There's a reason they call them dummy variables: a note on the use of structural equation techniques in comparative effectiveness research.

Authors:  William H Crown
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 4.  Retrospective economic and outcomes analyses using non-US databases: a review.

Authors:  Lizheng Shi; Eric Q Wu; Meredith Hodges; Andrew Yu; Howard Birnbaum
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 5.  A pathway to improved prospective observational post-authorization safety studies.

Authors:  Victor A Kiri
Journal:  Drug Saf       Date:  2012-09-01       Impact factor: 5.606

6.  Bootstrap analyses of cost effectiveness in antidepressant pharmacotherapy.

Authors:  R L Obenchain; C A Melfi; T W Croghan; D P Buesching
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

7.  The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: an application of random effect regression models and propensity scores in an observational prospective trial.

Authors:  Reinhold Kilian; Matthias C Angermeyer
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

8.  Using healthcare claims data for outcomes research and pharmacoeconomic analyses.

Authors:  H G Birnbaum; P Y Cremieux; P E Greenberg; J LeLorier; J A Ostrander; L Venditti
Journal:  Pharmacoeconomics       Date:  1999-07       Impact factor: 4.981

Review 9.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

10.  Preoperative use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers is associated with increased risk for acute kidney injury after cardiovascular surgery.

Authors:  Pradeep Arora; Srini Rajagopalam; Rajiv Ranjan; Hari Kolli; Manpreet Singh; Rocco Venuto; James Lohr
Journal:  Clin J Am Soc Nephrol       Date:  2008-07-30       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.